Company news

Bionano Genomics, Inc. news in 2025

Bionano Genomics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025

December 11, 2025

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

December 3, 2025

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress

November 13, 2025

Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia

November 6, 2025

Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025

October 30, 2025

Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting

October 23, 2025

Bionano to Participate in the H.C. Wainwright @ Home Event

October 7, 2025

Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering

September 17, 2025

Bionano Genomics, Inc. Announces Pricing of $10 Million Public Offering

September 16, 2025

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology

September 16, 2025

CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders

September 15, 2025

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference

August 25, 2025

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

August 14, 2025

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

August 7, 2025

Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference

August 6, 2025

Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More Accurate

August 5, 2025

Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025

July 31, 2025

Bionano Recaps Momentum behind Optical Genome Mapping at the Biennial Meeting of the European Cytogenomics Association Held Recently in Leuven, Belgium

July 30, 2025

Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy

June 18, 2025

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

May 14, 2025

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

May 7, 2025

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

May 2, 2025

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

April 23, 2025

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

April 8, 2025

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

March 31, 2025

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

March 24, 2025

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

March 18, 2025

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

March 14, 2025

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

March 13, 2025

Bionano Announces Effective Date of Reverse Stock Split

January 21, 2025

Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss

January 13, 2025

Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results

January 12, 2025

Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia

January 6, 2025

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

January 2, 2025

Calls in 2025

Decks in 2025